{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:12:43Z","timestamp":1792804363552,"version":"4.5.0"},"reference-count":36,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>Intrathecal baclofen (ITB) is an effective treatment for refractory hypertonia in children. ITB has long been effective for the treatment of spasticity, and indications have naturally evolved to include dystonia and mixed pediatric movement disorders (PMDs). The established uses for ITB trials are insurance prerequisite, mixed tone, and family request. Despite agreement for ITB therapy by a multidisciplinary group of subspecialists in a complex PMD program, insurance companies often require an ITB trial be performed. A longitudinal cohort was identified to determine the safety and efficacy of ITB trials and to determine the utility of test dosing in this population.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>Retrospective data analysis was performed for patients with hypertonia who underwent ITB bolus trials at the authors\u2019 institution between 2021 and 2023. Nonmodifiable risk factors and clinical variables were collected.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>Thirty-one patients (11 female) underwent 32 ITB trials. Of these patients, 67.7% had a diagnosis of mixed hypertonia, 32.3% pure spasticity, and 9.1% secondary dystonia. The mean age at test dose was 12.8 years, and 58.1% of patients were born premature. The mode Gross Motor Function Classification System score was 5. The mean difference in Barry-Albright Dystonia Scale (BADS) scores was \u22127.33 points (p = 0.01) at 2.5 hours postoperatively. The mean difference in upper-extremity modified Ashworth Scale (mAS) scores was \u22125.36 points (p = 0.003), and that for lower-extremity mAS scores was \u22126.61 (p &lt; 0.001). In total, 21.9% of patients developed a post\u2013dural puncture headache. Conversion to a permanent baclofen pump was performed in 22\/32 (68.8%) patients. Of those who did not pursue pump placement, 1 patient had high surgical risk, 1 had an ineffective response, 1 had a bad reaction to the test dose and cited both regression and increased discomfort, and 2 declined despite an effective trial owing to family preferences.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>ITB trials require hospitalization in some form and carry risks of procedural complications. The decision to pursue a trial should be made on a case-by-case basis by clinicians and should not be determined by insurance companies. The complication rate of ITB trials is high, and a test dose is unnecessary in this fragile population.<\/jats:p>\n<\/jats:sec>","DOI":"10.3171\/2023.11.peds23473","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T02:09:27Z","timestamp":1702087767000},"page":"179-184","source":"Crossref","is-referenced-by-count":10,"title":["Safety and efficacy of intrathecal baclofen trials for the treatment of hypertonia: a retrospective cohort study"],"prefix":"10.3171","volume":"33","author":[{"given":"Sunny","family":"Abdelmageed","sequence":"first","affiliation":[{"name":"Division of Pediatric Neurosurgery, Ann & Robert H. Lurie Children\u2019s Hospital, Chicago, Illinois;"},{"name":"Department of Neurosurgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria Jane","family":"Horak","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurosurgery, Ann & Robert H. Lurie Children\u2019s Hospital, Chicago, Illinois;"},{"name":"Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Mossner","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Wang","sequence":"additional","affiliation":[{"name":"Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Krater","sequence":"additional","affiliation":[{"name":"Shirley Ryan AbilityLab, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Raskin","sequence":"additional","affiliation":[{"name":"Division of Pediatric Neurosurgery, Ann & Robert H. Lurie Children\u2019s Hospital, Chicago, Illinois;"},{"name":"Department of Neurosurgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"9","key":"b1","series-title":"Childs Nerv Syst","first-page":"971","article-title":"Intrathecal baclofen for childhood hypertonia","volume":"23","author":"Albright AL","year":"2007","unstructured":"Albright AL. Intrathecal baclofen for childhood hypertonia. Childs Nerv Syst. 2007;23(9):971-979."},{"issue":"7","key":"b2","series-title":"Curr Probl Pediatr Adolesc Health Care","first-page":"161","article-title":"Hypertonia","volume":"47","author":"Evans SH","year":"2017","unstructured":"Evans SH, Cameron MW, Burton JM. Hypertonia. Curr Probl Pediatr Adolesc Health Care. 2017;47(7):161-166."},{"key":"b3","series-title":"J Electromyogr Kinesiol","first-page":"84","article-title":"Spasticity and spastic dystonia: the two faces of velocity-dependent hypertonia","volume":"37","author":"Marinelli L","year":"2017","unstructured":"Marinelli L, Curr\u00e0 A, Trompetto C,  Spasticity and spastic dystonia: the two faces of velocity-dependent hypertonia. J Electromyogr Kinesiol. 2017;37:84\u201389."},{"issue":"1","key":"b4","series-title":"Nat Rev Dis Primers","first-page":"25","article-title":"Dystonia","volume":"4","author":"Balint B","year":"2018","unstructured":"Balint B, Mencacci NE, Valente EM,  Dystonia. Nat Rev Dis Primers. 2018;4(1):25."},{"issue":"1","key":"b5","series-title":"J Neurosurg Pediatr","first-page":"102","article-title":"Conus-level combined dorsal and ventral lumbar rhizotomy for treatment of mixed hypertonia: technical note and complications","volume":"27","author":"Ahluwalia R","year":"2020","unstructured":"Ahluwalia R, Bass P, Flynn L,  Conus-level combined dorsal and ventral lumbar rhizotomy for treatment of mixed hypertonia: technical note and complications. J Neurosurg Pediatr. 2020;27(1):102-107."},{"issue":"1","key":"b6","series-title":"Pediatrics","first-page":"e89","article-title":"Classification and definition of disorders causing hypertonia in childhood","volume":"111","author":"Sanger TD","year":"2003","unstructured":"Sanger TD, Delgado MR, Gaebler-Spira D, Hallett M, Mink JW. Classification and definition of disorders causing hypertonia in childhood. Pediatrics. 2003;111(1):e89-e97."},{"issue":"20","key":"b7","series-title":"JAMA","first-page":"2475","article-title":"Continuous intrathecal baclofen infusion for spasticity of cerebral origin","volume":"270","author":"Albright AL","year":"1993","unstructured":"Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA. 1993;270(20):2475-2477."},{"issue":"2","key":"b8","series-title":"J Neurosurg Pediatr","first-page":"240","article-title":"Intrathecal baclofen trials: complications and positive yield in a pediatric cohort","volume":"17","author":"Sayer C","year":"2016","unstructured":"Sayer C, Lumsden DE, Perides S,  Intrathecal baclofen trials: complications and positive yield in a pediatric cohort. J Neurosurg Pediatr. 2016;17(2):240-245."},{"issue":"1","key":"b9","series-title":"J Neurosurg Pediatr","first-page":"11","article-title":"Intraventricular baclofen for dystonia: techniques and outcomes. Clinical article","volume":"3","author":"Albright AL","year":"2009","unstructured":"Albright AL, Ferson SS. Intraventricular baclofen for dystonia: techniques and outcomes. Clinical article. J Neurosurg Pediatr. 2009;3(1):11-14."},{"issue":"6","key":"b10","series-title":"J Child Neurol","first-page":"408","article-title":"Plasma baclofen levels in children receiving continuous intrathecal baclofen infusion","volume":"14","author":"Albright AL","year":"1999","unstructured":"Albright AL, Shultz BL. Plasma baclofen levels in children receiving continuous intrathecal baclofen infusion. J Child Neurol. 1999;14(6):408-409."},{"key":"b11","series-title":"World Neurosurg","first-page":"e59","article-title":"Infectious complications and operative management of intrathecal baclofen pumps in the pediatric population: a systematic review and meta-analysis of 20 years of pooled experience","volume":"163","author":"Nuru M","year":"2022","unstructured":"Nuru M, Maglinger B, Vessell M,  Infectious complications and operative management of intrathecal baclofen pumps in the pediatric population: a systematic review and meta-analysis of 20 years of pooled experience. World Neurosurg. 2022;163:e59\u2013e72."},{"issue":"1","key":"b12","series-title":"J Pediatr Orthop","first-page":"76","article-title":"Complications of intrathecal baclofen pump therapy in pediatric patients","volume":"30","author":"Borowski A","year":"2010","unstructured":"Borowski A, Littleton AG, Borkhuu B,  Complications of intrathecal baclofen pump therapy in pediatric patients. J Pediatr Orthop. 2010;30(1):76-81."},{"issue":"6","key":"b13","series-title":"Neuromodulation","first-page":"616","article-title":"Best practices for intrathecal baclofen therapy: screening test","volume":"19","author":"Boster AL","year":"2016","unstructured":"Boster AL, Bennett SE, Bilsky GS,  Best practices for intrathecal baclofen therapy: screening test. Neuromodulation. 2016;19(6):616-622."},{"issue":"7","key":"b14","series-title":"Cureus","first-page":"e26980","article-title":"Results of intrathecal baclofen treatment in sixteen spasticity patients according to four different measurement scales: a retrospective analysis","volume":"14","author":"G\u00fcnd\u00fcz HB","year":"2022","unstructured":"G\u00fcnd\u00fcz HB. Results of intrathecal baclofen treatment in sixteen spasticity patients according to four different measurement scales: a retrospective analysis. Cureus. 2022;14(7):e26980."},{"issue":"3","key":"b15","series-title":"Pediatr Neurosurg","first-page":"138","article-title":"Complications of intrathecal baclofen pumps in children: experience from a tertiary care center","volume":"49","author":"Ghosh D","year":"2013","unstructured":"Ghosh D, Mainali G, Khera J, Luciano M. Complications of intrathecal baclofen pumps in children: experience from a tertiary care center. Pediatr Neurosurg. 2013;49(3):138-144."},{"issue":"5","key":"b16","series-title":"J Child Orthop","first-page":"529","article-title":"Identification of complications in paediatric cerebral palsy treated with intrathecal baclofen pump: a descriptive analysis of 15 years at one institution","volume":"13","author":"Imerci A","year":"2019","unstructured":"Imerci A, Rogers KJ, Pargas C, Sees JP, Miller F. Identification of complications in paediatric cerebral palsy treated with intrathecal baclofen pump: a descriptive analysis of 15 years at one institution. J Child Orthop. 2019;13(5):529-535."},{"issue":"10","key":"b17","series-title":"PM R","first-page":"1052","article-title":"Clinical experience with continuous intrathecal baclofen trials prior to pump implantation","volume":"7","author":"Phillips MM","year":"2015","unstructured":"Phillips MM, Miljkovic N, Ramos-Lamboy M,  Clinical experience with continuous intrathecal baclofen trials prior to pump implantation. PM R. 2015;7(10):1052-1058."},{"issue":"4","key":"b18","series-title":"J Spinal Cord Med","first-page":"394","article-title":"Effect of intrathecal baclofen concentration on spasticity control: case series","volume":"31","author":"Saval A","year":"2008","unstructured":"Saval A, Chiodo AE. Effect of intrathecal baclofen concentration on spasticity control: case series. J Spinal Cord Med. 2008;31(4):394-397."},{"key":"b19","series-title":"Aetna","article-title":"Medical Clinical Policy Bulletins","unstructured":"Infusion Pumps. Medical Clinical Policy Bulletins. Aetna. Accessed November 17, 2023.https:\/\/www.aetna.com\/cpb\/medical\/data\/100_199\/0161.html"},{"issue":"8","key":"b20","series-title":"PM R","first-page":"802","article-title":"Does every patient require an intrathecal baclofen trial before pump placement?","volume":"8","author":"Bilsky GS","year":"2016","unstructured":"Bilsky GS, Saulino M, O\u2019Dell MW. Does every patient require an intrathecal baclofen trial before pump placement? PM R. 2016;8(8):802-807."},{"issue":"6","key":"b21","series-title":"Dev Med Child Neurol","first-page":"404","article-title":"Reliability and responsiveness of the Barry-Albright Dystonia Scale","volume":"41","author":"Barry MJ","year":"1999","unstructured":"Barry MJ, VanSwearingen JM, Albright AL. Reliability and responsiveness of the Barry-Albright Dystonia Scale. Dev Med Child Neurol. 1999;41(6):404-411."},{"key":"b22","series-title":"BMC Musculoskelet Disord","first-page":"44","article-title":"Reliability of Ashworth and Modified Ashworth scales in children with spastic cerebral palsy","volume":"9","author":"Mutlu A","year":"2008","unstructured":"Mutlu A, Livanelioglu A, Gunel MK. Reliability of Ashworth and Modified Ashworth scales in children with spastic cerebral palsy. BMC Musculoskelet Disord. 2008;9:44."},{"issue":"4","key":"b23","series-title":"Childs Nerv Syst","first-page":"767","article-title":"Intrathecal baclofen therapy for treatment of spasticity in infants and small children under 6 years of age","volume":"36","author":"Hagemann C","year":"2020","unstructured":"Hagemann C, Schmitt I, Lischetzki G, Kunkel P. Intrathecal baclofen therapy for treatment of spasticity in infants and small children under 6 years of age. Childs Nerv Syst. 2020;36(4):767-773."},{"issue":"1","key":"b24","series-title":"Dev Med Child Neurol","first-page":"94","article-title":"Intrathecal baclofen in dyskinetic cerebral palsy: effects on function and activity","volume":"60","author":"Eek MN","year":"2018","unstructured":"Eek MN, Olsson K, Lindh K,  Intrathecal baclofen in dyskinetic cerebral palsy: effects on function and activity. Dev Med Child Neurol. 2018;60(1):94-99."},{"issue":"2","key":"b25","series-title":"J Child Neurol","first-page":"71","article-title":"Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial","volume":"15","author":"Gilmartin R","year":"2000","unstructured":"Gilmartin R, Bruce D, Storrs BB,  Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J Child Neurol. 2000;15(2):71-77."},{"issue":"6","key":"b26","series-title":"PM R","first-page":"506","article-title":"Long-term intrathecal baclofen: outcomes after more than 10 years of treatment","volume":"6","author":"Mathur SN","year":"2014","unstructured":"Mathur SN, Chu SK, McCormick Z, Chang Chien GC, Marciniak CM. Long-term intrathecal baclofen: outcomes after more than 10 years of treatment. PM R. 2014;6(6):506-513.e1."},{"issue":"7","key":"b27","series-title":"J Pediatr Orthop","first-page":"817","article-title":"Upper limbs function after intrathecal baclofen therapy in children with secondary dystonia","volume":"29","author":"Motta F","year":"2009","unstructured":"Motta F, Antonello CE, Stignani C. Upper limbs function after intrathecal baclofen therapy in children with secondary dystonia. J Pediatr Orthop. 2009;29(7):817-821."},{"issue":"2","key":"b28","series-title":"J Pediatr Orthop","first-page":"213","article-title":"Effect of intrathecal baclofen on dystonia in children with cerebral palsy and the use of functional scales","volume":"28","author":"Motta F","year":"2008","unstructured":"Motta F, Stignani C, Antonello CE. Effect of intrathecal baclofen on dystonia in children with cerebral palsy and the use of functional scales. J Pediatr Orthop. 2008;28(2):213-217."},{"issue":"3","key":"b29","series-title":"World J Pediatr Surg","first-page":"e000407","article-title":"Management of severe spasticity with and without dystonia with intrathecal baclofen in the pediatric population: a cross-sectional study","volume":"5","author":"Gober J","year":"2022","unstructured":"Gober J, Seymour M, Miao H, Curry DJ, Thomas SP. Management of severe spasticity with and without dystonia with intrathecal baclofen in the pediatric population: a cross-sectional study. World J Pediatr Surg. 2022;5(3):e000407."},{"key":"b30","series-title":"Front Neurol","first-page":"901","article-title":"Intrathecal baclofen in hereditary spastic paraparesis","volume":"10","author":"Pucks-Faes E","year":"2019","unstructured":"Pucks-Faes E, Dobesberger J, Hitzenberger G,  Intrathecal baclofen in hereditary spastic paraparesis. Front Neurol. 2019;10:901."},{"issue":"3","key":"b31","series-title":"Eur J Paediatr Neurol","first-page":"565","article-title":"Long-term therapy with intrathecal baclofen improves quality of life in children with severe spastic cerebral palsy","volume":"21","author":"Kraus T","year":"2017","unstructured":"Kraus T, Gegenleitner K, Svehlik M, Novak M, Steinwender G, Singer G. Long-term therapy with intrathecal baclofen improves quality of life in children with severe spastic cerebral palsy. Eur J Paediatr Neurol. 2017;21(3):565-569."},{"issue":"34","key":"b32","series-title":"Medicine (Baltimore)","first-page":"e7472","article-title":"Outcomes of intrathecal baclofen therapy in patients with cerebral palsy and acquired brain injury","volume":"96","author":"Yoon YK","year":"2017","unstructured":"Yoon YK, Lee KC, Cho HE,  Outcomes of intrathecal baclofen therapy in patients with cerebral palsy and acquired brain injury. Medicine (Baltimore). 2017;96(34):e7472."},{"issue":"6","key":"b33","series-title":"Am J Phys Med Rehabil","first-page":"536","article-title":"Intrathecal baclofen pump use for spasticity: a clinical survey","volume":"79","author":"Stempien L","year":"2000","unstructured":"Stempien L, Tsai T. Intrathecal baclofen pump use for spasticity: a clinical survey. Am J Phys Med Rehabil. 2000;79(6):536-541."},{"issue":"1","key":"b34","series-title":"J Pediatr Nurs","first-page":"25","article-title":"Children with chronic conditions: perspectives on condition management","volume":"30","author":"Beacham BL","year":"2015","unstructured":"Beacham BL, Deatrick JA. Children with chronic conditions: perspectives on condition management. J Pediatr Nurs. 2015;30(1):25-35."},{"issue":"2","key":"b35","series-title":"Anesth Essays Res","first-page":"458","article-title":"The postdural puncture headache and back pain: the comparison of 26-gauge Atraucan and 26-gauge Quincke spinal needles in obstetric patients","volume":"11","author":"Akdemir MS","year":"2017","unstructured":"Akdemir MS, Kaydu A, Yanl\u0131 Y, \u00d6zdemir M, G\u00f6k\u00e7ek E, Karaman H. The postdural puncture headache and back pain: the comparison of 26-gauge Atraucan and 26-gauge Quincke spinal needles in obstetric patients. Anesth Essays Res. 2017;11(2):458-462."},{"key":"b36","series-title":"StatPearls","article-title":"Postdural Puncture Headache","author":"Plewa M","year":"2023","unstructured":"Plewa M, McAllister R. Postdural Puncture Headache. In: StatPearls. StatPearls Publishing; 2023."}],"container-title":["Journal of Neurosurgery: Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/33\/2\/article-p179.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/33\/2\/article-p179.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/33\/2\/article-p179.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T13:06:07Z","timestamp":1733490367000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/33\/2\/article-p179.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":36,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/2023.11.peds23473","relation":{},"ISSN":["1933-0707","1933-0715"],"issn-type":[{"value":"1933-0707","type":"print"},{"value":"1933-0715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}